Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $1.67 billion. The enterprise value is $1.98 billion.
Important Dates
The next confirmed earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 126.10 million shares outstanding. The number of shares has increased by 15.92% in one year.
| Current Share Class | 126.10M |
| Shares Outstanding | 126.10M |
| Shares Change (YoY) | +15.92% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 4.79% |
| Owned by Institutions (%) | 73.75% |
| Float | 108.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 664.79 |
| Forward PS | 6.41 |
| PB Ratio | 31.64 |
| P/TBV Ratio | 37.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 793.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.09, with a Debt / Equity ratio of 15.55.
| Current Ratio | 6.09 |
| Quick Ratio | 5.90 |
| Debt / Equity | 15.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.87 |
Financial Efficiency
Return on equity (ROE) is -565.33% and return on invested capital (ROIC) is -52.37%.
| Return on Equity (ROE) | -565.33% |
| Return on Assets (ROA) | -47.71% |
| Return on Invested Capital (ROIC) | -52.37% |
| Return on Capital Employed (ROCE) | -68.04% |
| Revenue Per Employee | $4,105 |
| Profits Per Employee | -$1.05M |
| Employee Count | 609 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $649,000 in taxes.
| Income Tax | 649,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.95% in the last 52 weeks. The beta is 0.90, so ARWR's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -46.95% |
| 50-Day Moving Average | 13.87 |
| 200-Day Moving Average | 19.43 |
| Relative Strength Index (RSI) | 50.23 |
| Average Volume (20 Days) | 1,556,889 |
Short Selling Information
The latest short interest is 12.53 million, so 9.94% of the outstanding shares have been sold short.
| Short Interest | 12.53M |
| Short Previous Month | 11.98M |
| Short % of Shares Out | 9.94% |
| Short % of Float | 11.60% |
| Short Ratio (days to cover) | 6.13 |
Income Statement
In the last 12 months, ARWR had revenue of $2.50 million and -$639.71 million in losses. Loss per share was -$5.15.
| Revenue | 2.50M |
| Gross Profit | 2.50M |
| Operating Income | -625.95M |
| Pretax Income | -539.92M |
| Net Income | -639.71M |
| EBITDA | -606.38M |
| EBIT | -625.95M |
| Loss Per Share | -$5.15 |
Full Income StatementBalance Sheet
The company has $550.84 million in cash and $872.05 million in debt, giving a net cash position of -$321.21 million or -$2.55 per share.
| Cash & Cash Equivalents | 550.84M |
| Total Debt | 872.05M |
| Net Cash | -321.21M |
| Net Cash Per Share | -$2.55 |
| Equity (Book Value) | 56.08M |
| Book Value Per Share | 0.42 |
| Working Capital | 476.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$491.28 million and capital expenditures -$80.33 million, giving a free cash flow of -$571.61 million.
| Operating Cash Flow | -491.28M |
| Capital Expenditures | -80.33M |
| Free Cash Flow | -571.61M |
| FCF Per Share | -$4.53 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -25,037.88% |
| Pretax Margin | -25,955.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.92% |
| Shareholder Yield | -15.92% |
| Earnings Yield | -38.49% |
| FCF Yield | -34.39% |
Dividend DetailsAnalyst Forecast
The average price target for ARWR is $41.44, which is 213.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $41.44 |
| Price Target Difference | 213.70% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 199.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
ARWR has an Altman Z-Score of -1.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.99 |
| Piotroski F-Score | 2 |